FFIVBuy
F5, Inc.
Price (1y)
Fair price check
6 different valuation methods each estimate what FFIV should be worth, then we compare to today's price.
- P/B multiplesUndervaluedthinks it's a bargain — estimates $663.42, about 83% above today
- P/E multiplesUndervaluedthinks it's a bargain — estimates $487.23, about 34% above today
- EV/EBITDAFairthinks it's fairly priced — estimates $419.84, about 16% above today
- DCF (2-stage)Overvaluedthinks it's expensive — estimates $166.38, about 54% below today
- Graham (defensive)Outlierestimate looks unreliable — estimates $63.66 — likely unreliable
- Residual IncomeOutlierestimate looks unreliable — estimates $26.55 — likely unreliable
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
| Method | Value |
|---|---|
| Graham (defensive) | $63.66 |
| P/E multiples(vs sector peers) | $487.23 |
| P/B multiples(vs sector peers) | $663.42 |
| EV/EBITDA(vs sector peers) | $419.84 |
| Residual Income | $26.55 |
| DCF (2-stage) | $166.38 |
- goodwill heavy
- extreme graham estimate
- extreme rim estimate
Median of all applicable methods (current price $362.58). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Pillar breakdown
8 dimensions, each scored 0–100 against the universe
- QualityProfit margins & asset efficiency59Decent
- ValuePrice vs fundamentals63Decent
- GrowthRevenue & earnings trajectory71Strong
- MomentumRecent price strength78Strong
- HealthBalance sheet & solvency84Strong
- ProfitabilityROE, ROA, ROIC65Decent
- TechnicalTrend & volatility signals69Decent
- RiskVolatility & drawdown profile53Decent
Pillars not shown: Sentiment, ML (Phase 5+).
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $20.46B |
| Revenue (TTM) | $3.22B |
| Net income (TTM) | $708.21M |
| Operating cash flow (TTM) | $1.02B |
| CapEx (TTM) | $52.75M |
| Free cash flow (TTM)CFO − CapEx | $962.66M |
| Total assets | $6.50B |
| Total liabilities | $1.63B |
| Stockholders' equity | $3.65B |
| Cash & equivalents | $1.44B |
| Shares outstanding | 56.42M |
| EPS (basic) | $5.73 |
| EPS (diluted) | $5.68 |
| P/E ratio (TTM) | 28.88 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-05-05
- Latest period end
- 2026-04-30
- Filing lag
- 11 days
- Missing metrics
- 2(interest_expense, dividends_paid)
Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.